<main class="publication" lang="en" role="main">
      



<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    

<div class="gem-c-title govuk-!-margin-top-8 govuk-!-margin-bottom-8">
      <span class="govuk-caption-xl gem-c-title__context">
    Decision
  </span>


  <h1 class="gem-c-title__text govuk-heading-l">
    Regulatory approval of Spikevax bivalent Original/Omicron booster vaccine
  </h1>
</div>
  </div>
  

  <div class="govuk-grid-column-two-thirds">
      <p class="gem-c-lead-paragraph">Information for healthcare professionals and the public on Moderna's bivalent vaccine. Information on the original Spikevax COVID-19 vaccine can found on a separate page (link below)</p>

  </div>
</div>

<div class="govuk-grid-row">
  <div class="metadata-logo-wrapper">
    <div class="govuk-grid-column-two-thirds metadata-column">
      <div class="gem-c-metadata govuk-!-margin-bottom-3" data-module="gem-toggle metadata">
  <dl data-module="gem-track-click">
      <dt class="gem-c-metadata__term">From:</dt>
      <dd class="gem-c-metadata__definition">
          <a class="govuk-link" href="/government/organisations/medicines-and-healthcare-products-regulatory-agency">Medicines and Healthcare products Regulatory Agency</a>

      </dd>
      <dt class="gem-c-metadata__term">Published</dt>
      <dd class="gem-c-metadata__definition">15 August 2022</dd>
  </dl>
</div>
    </div>
    <div class="govuk-grid-column-one-third">
    </div>
  </div>
</div>

<div class="govuk-!-display-none-print govuk-!-margin-bottom-6" data-module="gem-track-click">
  <form action="/email/subscriptions/single-page/new" class="gem-c-single-page-notification-button" data-button-location="top" data-track-action="Subscribe-button-top" data-track-category="Single-page-notification-button" data-track-label="/government/publications/regulatory-approval-of-spikevax-bivalent-originalomicron-booster-vaccine" method="POST">
    <input name="base_path" type="hidden" value="/government/publications/regulatory-approval-of-spikevax-bivalent-originalomicron-booster-vaccine">
    <button class="govuk-body-s gem-c-single-page-notification-button__submit" type="submit">  <svg class="gem-c-single-page-notification-button__icon" height="18" viewBox="0 0 459.334 459.334" width="18" xmlns="http://www.w3.org/2000/svg"><path d="M177.216 404.514c-.001.12-.009.239-.009.359 0 30.078 24.383 54.461 54.461 54.461s54.461-24.383 54.461-54.461c0-.12-.008-.239-.009-.359H175.216zM403.549 336.438l-49.015-72.002v-89.83c0-60.581-43.144-111.079-100.381-122.459V24.485C254.152 10.963 243.19 0 229.667 0s-24.485 10.963-24.485 24.485v27.663c-57.237 11.381-100.381 61.879-100.381 122.459v89.83l-49.015 72.002a24.76 24.76 0 0 0 20.468 38.693H383.08a24.761 24.761 0 0 0 20.469-38.694z" fill="currentColor"></path></svg>Get emails about this page
</button>
</form>
</div>






<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    <div class="responsive-bottom-margin">
      

      <div class="responsive-bottom-margin">
          <section>
    <h2 class="gem-c-heading gem-c-heading--font-size-27 gem-c-heading--mobile-top-margin">Documents</h2>


      
<div class="gem-c-govspeak govuk-govspeak direction-ltr" data-module="govspeak">
    
        <section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1097996/Spikexax_bivalent_Original_Omicron_SmPC.pdf" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1097996/thumbnail_Spikexax_bivalent_Original_Omicron_SmPC.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a aria-describedby="attachment-6831788-accessibility-help" class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1097996/Spikexax_bivalent_Original_Omicron_SmPC.pdf">Summary of Product Characteristics Spikevax bivalent Original/Omicron </a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">476 KB</span>, <span class="page-length" lang="en">21 pages</span>
    </p>


      <div class="accessibility-warning" data-module="toggle">
        <p class="govuk-body">This file may not be suitable for users of assistive technology.</p>
        <details class="gem-c-details govuk-details govuk-!-margin-bottom-3" data-module="govuk-details gem-details">
  <summary class="govuk-details__summary" data-details-track-click="" data-module="govuk-details" data-track-action="FormatRequestClicked" data-track-category="Accessible Format Request" data-track-label="Summary of Product Characteristics Spikevax bivalent Original/Omicron ">
    <span class="govuk-details__summary-text">
      Request an accessible format.
    </span>
</summary>  <div class="govuk-details__text">
    
          If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email <a href="mailto:webupdates@mhra.gov.uk?body=Details%20of%20document%20required%3A%0A%0A%20%20Title%3A%20Summary%20of%20Product%20Characteristics%20Spikevax%20bivalent%20Original%2FOmicron%20%0A%20%20Original%20format%3A%20pdf%0A%0APlease%20tell%20us%3A%0A%0A%20%201.%20What%20makes%20this%20format%20unsuitable%20for%20you%3F%0A%20%202.%20What%20format%20you%20would%20prefer%3F%0A%20%20%20%20%20%20&amp;subject=Request%20for%20%27Summary%20of%20Product%20Characteristics%20Spikevax%20bivalent%20Original%2FOmicron%20%27%20in%20an%20alternative%20format">webupdates@mhra.gov.uk</a>.
Please tell us what format you need. It will help us if you say what assistive technology you use.


  </div>
</details>      </div>
  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1097997/Spikexax_bivalent_Original_Omicron_PIL.pdf" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1097997/thumbnail_Spikexax_bivalent_Original_Omicron_PIL.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a aria-describedby="attachment-6831789-accessibility-help" class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1097997/Spikexax_bivalent_Original_Omicron_PIL.pdf">Patient Information Leaflet Spikevax bivalent Original/Omicron </a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">245 KB</span>, <span class="page-length" lang="en">8 pages</span>
    </p>


      <div class="accessibility-warning" data-module="toggle">
        <p class="govuk-body">This file may not be suitable for users of assistive technology.</p>
        <details class="gem-c-details govuk-details govuk-!-margin-bottom-3" data-module="govuk-details gem-details">
  <summary class="govuk-details__summary" data-details-track-click="" data-module="govuk-details" data-track-action="FormatRequestClicked" data-track-category="Accessible Format Request" data-track-label="Patient Information Leaflet Spikevax bivalent Original/Omicron ">
    <span class="govuk-details__summary-text">
      Request an accessible format.
    </span>
</summary>  <div class="govuk-details__text">
    
          If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email <a href="mailto:webupdates@mhra.gov.uk?body=Details%20of%20document%20required%3A%0A%0A%20%20Title%3A%20Patient%20Information%20Leaflet%20Spikevax%20bivalent%20Original%2FOmicron%20%0A%20%20Original%20format%3A%20pdf%0A%0APlease%20tell%20us%3A%0A%0A%20%201.%20What%20makes%20this%20format%20unsuitable%20for%20you%3F%0A%20%202.%20What%20format%20you%20would%20prefer%3F%0A%20%20%20%20%20%20&amp;subject=Request%20for%20%27Patient%20Information%20Leaflet%20Spikevax%20bivalent%20Original%2FOmicron%20%27%20in%20an%20alternative%20format">webupdates@mhra.gov.uk</a>.
Please tell us what format you need. It will help us if you say what assistive technology you use.


  </div>
</details>      </div>
  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1098074/Spikexax_bivalent_Original_Omicron_Information_for_Healthcare_Professionals__Regulation_174_.pdf" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1098074/thumbnail_Spikexax_bivalent_Original_Omicron_Information_for_Healthcare_Professionals__Regulation_174_.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a aria-describedby="attachment-6832334-accessibility-help" class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1098074/Spikexax_bivalent_Original_Omicron_Information_for_Healthcare_Professionals__Regulation_174_.pdf">Spikevax bivalent Original/Omicron Information for Healthcare Professionals (Regulation 174)</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">476 KB</span>, <span class="page-length" lang="en">23 pages</span>
    </p>


      <div class="accessibility-warning" data-module="toggle">
        <p class="govuk-body">This file may not be suitable for users of assistive technology.</p>
        <details class="gem-c-details govuk-details govuk-!-margin-bottom-3" data-module="govuk-details gem-details">
  <summary class="govuk-details__summary" data-details-track-click="" data-module="govuk-details" data-track-action="FormatRequestClicked" data-track-category="Accessible Format Request" data-track-label="Spikevax bivalent Original/Omicron Information for Healthcare Professionals (Regulation 174)">
    <span class="govuk-details__summary-text">
      Request an accessible format.
    </span>
</summary>  <div class="govuk-details__text">
    
          If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email <a href="mailto:webupdates@mhra.gov.uk?body=Details%20of%20document%20required%3A%0A%0A%20%20Title%3A%20Spikevax%20bivalent%20Original%2FOmicron%20Information%20for%20Healthcare%20Professionals%20%28Regulation%20174%29%0A%20%20Original%20format%3A%20pdf%0A%0APlease%20tell%20us%3A%0A%0A%20%201.%20What%20makes%20this%20format%20unsuitable%20for%20you%3F%0A%20%202.%20What%20format%20you%20would%20prefer%3F%0A%20%20%20%20%20%20&amp;subject=Request%20for%20%27Spikevax%20bivalent%20Original%2FOmicron%20Information%20for%20Healthcare%20Professionals%20%28Regulation%20174%29%27%20in%20an%20alternative%20format">webupdates@mhra.gov.uk</a>.
Please tell us what format you need. It will help us if you say what assistive technology you use.


  </div>
</details>      </div>
  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1098080/Spikexax_bivalent_Original_Omicron_PIL__Regulation_174_.pdf" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1098080/thumbnail_Spikexax_bivalent_Original_Omicron_PIL__Regulation_174_.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a aria-describedby="attachment-6832339-accessibility-help" class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1098080/Spikexax_bivalent_Original_Omicron_PIL__Regulation_174_.pdf">Spikevax bivalent Original/Omicron Patient Information Leaflet (Regulation 174) </a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">244 KB</span>, <span class="page-length" lang="en">8 pages</span>
    </p>


      <div class="accessibility-warning" data-module="toggle">
        <p class="govuk-body">This file may not be suitable for users of assistive technology.</p>
        <details class="gem-c-details govuk-details govuk-!-margin-bottom-3" data-module="govuk-details gem-details">
  <summary class="govuk-details__summary" data-details-track-click="" data-module="govuk-details" data-track-action="FormatRequestClicked" data-track-category="Accessible Format Request" data-track-label="Spikevax bivalent Original/Omicron Patient Information Leaflet (Regulation 174) ">
    <span class="govuk-details__summary-text">
      Request an accessible format.
    </span>
</summary>  <div class="govuk-details__text">
    
          If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email <a href="mailto:webupdates@mhra.gov.uk?body=Details%20of%20document%20required%3A%0A%0A%20%20Title%3A%20Spikevax%20bivalent%20Original%2FOmicron%20Patient%20Information%20Leaflet%20%28Regulation%20174%29%20%0A%20%20Original%20format%3A%20pdf%0A%0APlease%20tell%20us%3A%0A%0A%20%201.%20What%20makes%20this%20format%20unsuitable%20for%20you%3F%0A%20%202.%20What%20format%20you%20would%20prefer%3F%0A%20%20%20%20%20%20&amp;subject=Request%20for%20%27Spikevax%20bivalent%20Original%2FOmicron%20Patient%20Information%20Leaflet%20%28Regulation%20174%29%20%27%20in%20an%20alternative%20format">webupdates@mhra.gov.uk</a>.
Please tell us what format you need. It will help us if you say what assistive technology you use.


  </div>
</details>      </div>
  </div>
</section>

</div>
  </section>


        <section>
          <h2 class="gem-c-heading gem-c-heading--font-size-27 gem-c-heading--mobile-top-margin">Details</h2>


          
<div class="gem-c-govspeak govuk-govspeak direction-ltr" data-module="govspeak">
    
            <div class="govspeak">
<div class="call-to-action">
<p>The 15-minute observation period following vaccination with the mRNA COVID-19 vaccines has been removed for individuals aged 12 years and over who have no history of a severe allergic reaction (as outlined in the <a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1057798/Greenbook-chapter-14a-28Feb22.pdf" rel="external">Greenbook advice</a> This follows careful review of the safety data by the MHRA and advice from the government’s independent Commission on Human Medicines. A temporary suspension of the 15-minute observation period for children aged 5-11 years remains in place and this will be reviewed on a regular basis.</p>
</div>

<div class="call-to-action">
<p>The product information for the Spikevax original COVID-19 vaccine (formerly COVID-19 Vaccine Moderna) can be found on a <a class="govuk-link" href="https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna#:~:text=Spikevax%20is%20authorised%20in%20Northern,information%20in%20our%20press%20release.">separate page</a>.</p>
</div>

<p>The MHRA has issued a Conditional Marketing Authorisation for Spikevax bivalent Original/Omicron booster vaccine in Great Britain and a temporary Regulation 174 authorisation for Northern Ireland to ensure supply across all of the UK. If the European Medicines Agency grants a CMA for Spikevax bivalent Original/Omicron booster vaccine it would apply in Northern Ireland and the Regulation 174 authorisation would no longer be in place.</p>

<p>Supply of this product will be subject to the same requirements in Great Britain and Northern Ireland.</p>

<p>The information for healthcare professionals and UK recipients on using the bivalent vaccine safely will be periodically updated as new data become available and this will continue when the CMA is converted to a MA. Please regularly check this information as it is often updated.</p>

<p>The Public Assessment Report will be published shortly.</p>

<h2>Summary of Product Characteristics (also referred to as the Information for Healthcare Professionals under R174)</h2>

<p>This is a description of a medicinal product’s properties and the conditions attached to its use. It explains how to use and prescribe a medicine. It is used by healthcare professionals, such as doctors, nurses and pharmacists.</p>

<h2>Patient Information Leaflet</h2>

<p>The Patient Information Leaflet provides information for patients on using the medicine safely. This is based on the Summary of Product Characteristics of the product.</p>

<h2>Public Assessment Report</h2>

<p>The Public Assessment Report is a scientific report, written by the MHRA. It explains how this product was assessed and its authorisation recommended, as well as its conditions of use. It is not intended to provide practical advice on how to use this product.</p>
</div>

</div>
        </section>
      </div>
      
<div class="app-c-published-dates govuk-!-margin-bottom-3" lang="en">
    Published 15 August 2022
</div>

<div class="govuk-!-display-none-print govuk-!-margin-bottom-0" data-module="gem-track-click">
  <form action="/email/subscriptions/single-page/new" class="gem-c-single-page-notification-button" data-button-location="bottom" data-track-action="Subscribe-button-bottom" data-track-category="Single-page-notification-button" data-track-label="/government/publications/regulatory-approval-of-spikevax-bivalent-originalomicron-booster-vaccine" method="POST">
    <input name="base_path" type="hidden" value="/government/publications/regulatory-approval-of-spikevax-bivalent-originalomicron-booster-vaccine">
    <button class="govuk-body-s gem-c-single-page-notification-button__submit" type="submit">  <svg class="gem-c-single-page-notification-button__icon" height="18" viewBox="0 0 459.334 459.334" width="18" xmlns="http://www.w3.org/2000/svg"><path d="M177.216 404.514c-.001.12-.009.239-.009.359 0 30.078 24.383 54.461 54.461 54.461s54.461-24.383 54.461-54.461c0-.12-.008-.239-.009-.359H175.216zM403.549 336.438l-49.015-72.002v-89.83c0-60.581-43.144-111.079-100.381-122.459V24.485C254.152 10.963 243.19 0 229.667 0s-24.485 10.963-24.485 24.485v27.663c-57.237 11.381-100.381 61.879-100.381 122.459v89.83l-49.015 72.002a24.76 24.76 0 0 0 20.468 38.693H383.08a24.761 24.761 0 0 0 20.469-38.694z" fill="currentColor"></path></svg>Get emails about this page
</button>
</form>
</div>

    </div>
  </div>
  
<div class="govuk-grid-column-one-third">
  


</div>

</div>


  <div class="govuk-grid-row">
    <div class="govuk-grid-column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav class="gem-c-related-navigation__nav-section" data-module="gem-toggle" role="navigation">

    <h2 class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer" data-track-count="footerRelatedItemSection">Explore the topic</h2>

  <ul class="gem-c-related-navigation__link-list" data-module="gem-track-click">


        <li class="gem-c-related-navigation__link"><a class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" data-track-action="1.1 Explore the topic" data-track-category="relatedLinkClicked" data-track-label="/topic/medicines-medical-devices-blood/marketing-authorisations-variations-licensing" data-track-options="{&quot;dimension28&quot;:&quot;1&quot;,&quot;dimension29&quot;:&quot;Marketing authorisations, variations and licensing guidance&quot;}" href="/topic/medicines-medical-devices-blood/marketing-authorisations-variations-licensing">Marketing authorisations, variations and licensing guidance</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>


    </main>